Literature DB >> 33156104

Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.

Vijay S Are1,2, Shannon M Knapp3, Ambar Banerjee4, Hani Shamseddeen1,2, Marwan Ghabril1,2, Eric Orman1,2, Kavish R Patidar1,2, Naga Chalasani1,2, Archita P Desai1,2.   

Abstract

INTRODUCTION: With increasing burden of obesity and liver disease in the United States, a better understanding of bariatric surgery in context of cirrhosis is needed. We described trends of hospital-based outcomes of bariatric surgery among cirrhotics and determined effect of volume status and type of surgery on these outcomes.
METHODS: In this population-based study, admissions for bariatric surgery were extracted from the National Inpatient Sample using International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes from 2004 to 2016 and grouped by cirrhosis status, type of bariatric surgery, and center volume. In-hospital mortality, complications, and their trends were compared between these groups using weighted counts, odds ratios [ORs], and logistic regression.
RESULTS: Among 1,679,828 admissions for bariatric surgery, 9,802 (0.58%) had cirrhosis. Cirrhosis admissions were more likely to be in white men, had higher Elixhauser Index, and higher in-hospital complications rates including death (1.81% vs 0.17%), acute kidney injury (4.5% vs 1.2%), bleeding (2.9% vs 1.1%), and operative complications (2% vs 0.6%) (P < 0.001 for all) compared to those without cirrhosis. Overtime, restrictive surgeries have grown in number (12%-71%) and complications rates have trended down in both groups. Cirrhotics undergoing bariatric surgery at low-volume centers (<50 procedures per year) and nonrestrictive surgery had a higher inpatient mortality rate (adjusted OR 4.50, 95% confidence interval 3.14-6.45, adjusted OR 4.00, 95% confidence interval 2.68-5.97, respectively). DISCUSSION: Contemporary data indicate that among admissions for bariatric surgery, there is a shift to restrictive-type surgeries with an improvement in-hospital complications and mortality. However, patients with cirrhosis especially those at low-volume centers have significantly higher risk of worse outcomes (see Visual abstract, Supplementary Digital Content, http://links.lww.com/AJG/B648).

Entities:  

Mesh:

Year:  2020        PMID: 33156104      PMCID: PMC8021461          DOI: 10.14309/ajg.0000000000000911

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   12.045


  38 in total

1.  Surgical volume impacts bariatric surgery mortality: a case for centers of excellence.

Authors:  Christopher S Hollenbeak; Ann M Rogers; Bryan Barrus; Irfan Wadiwala; Robert N Cooney
Journal:  Surgery       Date:  2008-07-21       Impact factor: 3.982

Review 2.  Evolution of bariatric surgery: a historical perspective.

Authors:  Mariam Moshiri; Sherif Osman; Tracy J Robinson; Saurabh Khandelwal; Puneet Bhargava; Charles A Rohrmann
Journal:  AJR Am J Roentgenol       Date:  2013-07       Impact factor: 3.959

3.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

4.  Safety and efficacy of bariatric surgery in patients with advanced fibrosis.

Authors:  T Singh; G S Kochhar; G B Goh; P Schauer; S Brethauer; M Kroh; A Aminian; R Lopez; S Dasarathy; A J McCullough
Journal:  Int J Obes (Lond)       Date:  2016-11-24       Impact factor: 5.095

5.  Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.

Authors:  Annalisa Berzigotti; Guadalupe Garcia-Tsao; Jaime Bosch; Norman D Grace; Andrew K Burroughs; Rosa Morillas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Roberto J Groszmann
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

6.  Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.

Authors:  Kanthi Yalamanchili; Sherif Saadeh; Göran B Klintmalm; Linda W Jennings; Gary L Davis
Journal:  Liver Transpl       Date:  2010-04       Impact factor: 5.799

7.  Increased perioperative mortality following bariatric surgery among patients with cirrhosis.

Authors:  Jeffrey D Mosko; Geoffrey C Nguyen
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-23       Impact factor: 11.382

8.  Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis.

Authors:  John G Kral; Swan N Thung; Simon Biron; Frederic-Simon Hould; Stefane Lebel; Simon Marceau; Serge Simard; Picard Marceau
Journal:  Surgery       Date:  2004-01       Impact factor: 3.982

9.  Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension.

Authors:  Zubaidah Nor Hanipah; Suriya Punchai; Arthur McCullough; Srinivasan Dasarathy; Stacy A Brethauer; Ali Aminian; Philip R Schauer
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

10.  Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis.

Authors:  Matthew J Klebanoff; Kathleen E Corey; Sumeyye Samur; Jin G Choi; Lee M Kaplan; Jagpreet Chhatwal; Chin Hur
Journal:  JAMA Netw Open       Date:  2019-02-01
View more
  2 in total

Review 1.  Bariatric Surgery in NAFLD.

Authors:  Mahak Chauhan; Kuldeep Singh; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2022-01-04       Impact factor: 3.199

2.  Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.

Authors:  Archita P Desai; Marion Greene; Lauren D Nephew; Eric S Orman; Marwan Ghabril; Naga Chalasani; Nir Menachemi
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.